<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13D
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
RULE 13d-2(a)
Commission File Number: 0-14026
DALTEX MEDICAL SCIENCES, INC.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.01 Par Value
- --------------------------------------------------------------------------------
(Title of Class of Securities)
235502 10 1
- --------------------------------------------------------------------------------
(CUSIP Number)
Robert Hausman, 1900 Corporate Boulevard, #400-E,
Boca Raton, FL 33431, (561)988-2544
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
February 1, 1999
- --------------------------------------------------------------------------------
(Date of Event Which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G
to report the acquisition that is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the
following box. |_|
<PAGE>
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Robert Hausman
______________________________________________________________________________
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [X]
______________________________________________________________________________
3 SEC USE ONLY
______________________________________________________________________________
4 SOURCE OF FUNDS
PF
______________________________________________________________________________
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEM 2(d) OR 2(e) [ ]
______________________________________________________________________________
6 CITIZENSHIP OR PLACE OF ORGANIZATION
USA/Florida
_______________________________________________________________________________
| |
NUMBER OF | 7 | SOLE VOTING POWER
SHARES | | 30,000,300
BENEFICIALLY |_____|________________________________________________________
OWNED BY | |
EACH | 8 | SHARED VOTING POWER
REPORTING | | 30,000,300
PERSON WITH |_____|________________________________________________________
| |
| 9 | SOLE DISPOSITIVE POWER
| | 30,000,300
|_____|________________________________________________________
| |
| 10 | SHARED DISPOSITIVE POWER
| | 0
_______________|_____|_________________________________________________________
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
30,000,300
______________________________________________________________________________
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES [ ]
______________________________________________________________________________
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
30.42%
______________________________________________________________________________
14 TYPE OF REPORTING PERSON
IN
______________________________________________________________________________
2
<PAGE>
Item 1. Security and Issuer.
This Statement relates to the shares of common stock of Daltex
Medical Sciences, Inc., a Delaware corporation having a principal business and
the address of its principal office at 7777 Glades Road, Suite 211, Boca Raton,
Florida 33434.
Item 2. Identity and Background.
a. Mr. Hausman is an investor in the issuer. His father,
Bruce Hausman, is an officer, director and
shareholder of the issuer.
b. The office address of Mr. Hausman is 1900 Corporate
Blvd.,#400-E, Boca Raton, Florida 33431.
c. Mr. Hausman has not been convicted in a criminal
proceeding and is not subject to a judgment, decree
or final order enjoining future violations of, or
prohibiting or mandating activities subject to,
federal or state securities laws, nor has there been
any finding or violation with respect to any such
laws.
e. During the past five years Mr. Hausman has not been a
party to a civil proceeding of a judicial
administrative body of competent jurisdiction as a
result of which proceeding it was or is subject to a
judgment, decree or final order enjoining future
violations of, or prohibiting or mandating activities
subject to, federal or state securities laws, or
finding any violation or which found any violation
with respect to such laws.
f. Mr. Hausman is an American citizen.
Item 3. Source and Amount of Funds or Other Consideration.
Mr. Hausman used his own funds to purchase common and Series A
Convertible Preferred Stock of the issuer. No part of the consideration was
borrowed.
Item 4. Purpose of Transaction.
The purpose of the transaction was to acquire a significant
position in the issuer with a view to having the issuer acquire, or be acquired
by, another corporation in a merger or other business combination involving the
issuer. No such transaction has been identified as of the date of this Report.
3
<PAGE>
The reporting person anticipates that the issuer will
materially change its present capitalization through an increase in the number
of authorized shares, a reverse split of the authorized shares outstanding, or
both.
Item 5. Interest in Securities of the Issuer.
Mr. Hausman is the beneficial owner of 30,000,300 shares of
common stock, which includes 333,300 shares of common stock held by him of
record and 29,667,000 shares of common stock underlying 29,667 shares of Series
A Convertible Preferred Stock of the issuer held by him. Mr. Hausman has sole
power to vote the shares of common stock issued to him and, as each share of
Series A Convertible Preferred Stock has a vote equivalent to 1,000 shares of
common stock, he has the sole power to vote the equivalent of 29,667,000 shares
of common stock in any vote of shareholders except a vote requiring a separate
vote by class. Mr. Hausman has the power to dispose or direct the disposition of
all of the shares owned by him of record or beneficially. He disclaims
beneficial ownership of any other shares of the issuer's common stock held by
any other person. He disclaims that he is part of any group. Mr. Hausman
acquired shares of the issuer's common stock and shares of the issuer's Series A
Convertible Preferred Stock on February 1, 1999, although the issuer did not
file a certificate of designations in Delaware with respect to its Series A
Convertible Preferred Stock until June 10, 1999.
Item 6. Contracts, Arrangements, Understandings or Relationships With
Respect to Securities of the Issuer.
None.
Item 7. Material to be Filed as Exhibits.
None.
4
<PAGE>
SIGNATURE
---------
After reasonable inquiry and to the best of our knowledge and belief,
we each certify that the information set forth in this statement is true,
complete and correct.
June 24th, 1999
-----------------------------------
(Date)
/s/ Robert Hausman
-----------------------------------
Robert Hausman
5
